Description

Lomexin Vaginal Cream 2% 78g. №1 Tube with Applicator

Ingredients:

Lomexin Vaginal Cream contains 2% of fenticonazole nitrate as the active ingredient. Other ingredients include cetostearyl alcohol, sorbitan stearate, polysorbate 60, liquid paraffin, and purified water.

Dosage:

For adult women: The usual dose is a single application of the cream (5g) into the vagina at bedtime for 3 consecutive days. Consult a healthcare provider for personalized dosing instructions.

Indications:

Lomexin Vaginal Cream is indicated for the treatment of vulvovaginal candidiasis (vaginal yeast infections) caused by Candida.

Contraindications:

Do not use Lomexin Vaginal Cream if you are allergic to any of the ingredients. Avoid using this product during menstruation.

Directions:

Before application, wash and dry your hands and the vaginal area. Insert the applicator gently into the vagina and press the plunger to release the cream. Wash the applicator thoroughly after each use.

Scientific Evidence:

Studies have shown that fenticonazole nitrate, the active ingredient in Lomexin Vaginal Cream, effectively treats vulvovaginal candidiasis with high cure rates and minimal side effects. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the efficacy of fenticonazole in eradicating Candida species.

Additional Information:

It is important to complete the full course of treatment with Lomexin Vaginal Cream even if symptoms improve to prevent recurrence. Avoid using tampons, douches, or other vaginal products during treatment. If symptoms persist or worsen, consult a healthcare professional.

Pharmacological Effects: Fenticonazole nitrate, a broad-spectrum antifungal agent, inhibits the growth of Candida species by disrupting their cell membranes. This action leads to the death of the fungal cells, effectively treating the infection.

Clinical Trials: Clinical trials have demonstrated the superior efficacy of Lomexin Vaginal Cream compared to placebo and other antifungal treatments in the management of vaginal yeast infections. Patients treated with fenticonazole showed rapid symptom relief and lower recurrence rates.